CHMP recommends Jyseleca, a once daily treatment for Rheumatoid Arthritis.- Gilead Sciences + Galapagos NV
Gilead Sciences, Inc.and Galapagos NV announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Jyseleca (filgotinib 200… read more.